Borosil (BOROLTD) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
8 Jul, 2026Executive summary
Revenue from operations for H1 FY 2025 reached ₹490.7 crores, up 19.4% year-over-year, reflecting strong demand and effective strategy execution.
Operating EBITDA for H1 FY 2025 was ₹86.9 crores, up 44.1% year-over-year, with an EBITDA margin of 16.8% versus 15.1% last year.
Profit after tax for H1 FY 2025 was ₹27.6 crores, up 17.6% year-over-year, despite higher depreciation and finance costs due to new capacity and increased tax expense.
The company successfully raised ₹150 crores via QIP, primarily used for loan repayments, improving the credit profile.
Board approved unaudited financial results for the quarter and half year ended September 30, 2024, and appointed new independent directors.
Financial highlights
Q2 FY25 net sales were ₹273.9 crores, up 16.6% year-over-year; EBITDA was ₹50.2 crores, up 27.7% year-over-year; PAT was ₹18.3 crores, impacted by higher taxation.
Net debt reduced to ₹88.6 crores at period end from ₹111.5 crores in H1 FY24 after QIP proceeds utilization.
Other income included ₹8.42 crores from shared service support, with related expenses in total expenses.
Basic and diluted EPS for Q2 FY25 stood at ₹1.53, and for the half-year at ₹2.36.
ICRA upgraded the long-term rating to AA- stable and reaffirmed short-term rating at A1+.
Outlook and guidance
Management maintains a 15%-20% short- to medium-term revenue growth guidance, focusing on premiumization, new product development, and e-commerce acceleration.
Capacity utilization for opalware is at 100% for Q2 and 85% for H1, with plans to optimize to full capacity within two years.
No immediate plans for new CapEx in Gujarat; annual CapEx for FY 2025 estimated at ₹100 crores, split across solar projects, furnace rebuilds, and de-bottlenecking.
QIP proceeds are being used for repayment/prepayment of loans and general corporate purposes, with unutilized funds temporarily invested in mutual funds.
Latest events from Borosil
- Q2 EBITDA and PAT outpaced revenue growth as H1 margins expanded.BOROLTD
Q2 26/27 - Demerger expanded FY20 results, while COVID-19 clouded near-term demand and recovery.BOROLTD
Q4 19/20 - Higher profit despite lower sales, with pharma packaging offsetting pandemic pressure.BOROLTD
Q4 20/21 - FY22 delivered 43.6% revenue growth and doubled PAT despite cost pressure and one-time losses.BOROLTD
Q4 21/22 - Revenue rose 22% as capacity and portfolio expansion advanced, while margins compressed.BOROLTD
Q4 22/23 - Q1 FY27 revenue rose 9% YoY, gross margin hit 69.1%, with margin recovery initiatives underway.BOROLTD
Q1 26/27 - 9MFY26 revenue up 9% YoY, glassware strong, Q3 profit down on one-offs, margin outlook positive.BOROLTD
Q3 25/26 - Q1 FY25 saw strong revenue and profit growth, margin gains, and reduced debt after QIP.BOROLTD
Q1 24/25 - Revenue and profit rose in FY25, driven by capacity expansion and strategic investments.BOROLTD
Q4 24/25